MedTrace Logo

Deep Transcranial Magnetic Stimulation (dTMS) for the Treatment of Premenstrual Dysphoric Disorder (PMDD)

NCT02448836 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2015-05-20

No results posted yet for this study

Summary

Premenstrual dysphoric disorder (PMDD) is a hormone-dependent mental condition that causes significant suffering in 5% of women of reproductive age worldwide. The prominent symptoms are depressed mood, irritability, mood lability and anxiety. Treatment options for PMDD are limited, with 40% non-responders.

Deep transcranial magnetic stimulation (dTMS) is a novel therapeutic technique, which is based on modulating neural activity by inducing an electric field in the brain. To date, dTMS was found to be an effective treatment for depression, which is highly comorbid with PMDD.

The investigators propose to study the effect of dTMS on PMDD patients in a prospective treatment study.

Conditions

  • Premenstrual Dysphoric Disorder

Interventions

DEVICE

dTMS H-coil system:magstim stimulator rapid2,BrainswayH1coil

Patients will undergo 8 sessions of dTMS treatment for two weeks (4 sessions every week).

DEVICE

Sham: dTMS H-coil system:magstim stimulator rapid2,BrainswayH1coil

Patients will undergo 8 sessions of Sham dTMS treatment for two weeks (4 sessions every week).

Sponsors & Collaborators

  • Tel-Aviv Sourasky Medical Center

    lead OTHER_GOV

Principal Investigators

  • Oren Tene, M.D · TASMC Israel

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-06-30
Primary Completion
2016-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02448836 on ClinicalTrials.gov